Mometasone/formoterol (200/10 or 400/10 microg/dose) vs salmeterol/fluticasone propionate in patients with mild-to-moderate asthma

Trial Profile

Mometasone/formoterol (200/10 or 400/10 microg/dose) vs salmeterol/fluticasone propionate in patients with mild-to-moderate asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2013

At a glance

  • Drugs Mometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Pharmacodynamics
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 04 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top